Cargando…

Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma

BACKGROUND: The pathologic distinction between high-grade prostate adenocarcinoma (PAC) involving the urinary bladder and high-grade urothelial carcinoma (UC) infiltrating the prostate can be difficult. However, making this distinction is clinically important because of the different treatment modal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Woo Jin, Chung, Arthur Minwoo, Kim, Jee Soon, Han, Ji Heun, Hong, Sung Hoo, Lee, Ji Yeol, Choi, Yeong Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042899/ https://www.ncbi.nlm.nih.gov/pubmed/27498545 http://dx.doi.org/10.4132/jptm.2016.06.14

Ejemplares similares

Proteomic-Based Machine Learning Analysis Reveals PYGB as a Novel Immunohistochemical Biomarker to Distinguish Inverted Urothelial Papilloma From Low-Grade Papillary Urothelial Carcinoma With Inverted Growth
por: Jung, Minsun, et al.
Publicado: (2022)

KRAS Mutation Test in Korean Patients with Colorectal Carcinomas: A Methodological Comparison between Sanger Sequencing and a Real-Time PCR-Based Assay
por: Lee, Sung Hak, et al.
Publicado: (2017)

Cytological Findings of the Micropapillary Variant of Urothelial Carcinoma: A Comparison with Typical High-Grade Urothelial Carcinoma
por: Kim, Kyu-Ho, et al.
Publicado: (2013)

Nuclear features of infiltrating urothelial carcinoma are distinguished from low-grade noninvasive papillary urothelial carcinoma by image analysis
por: Kosuge, Noritake, et al.
Publicado: (2017)

Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma
por: Srinivasan, Malini, et al.
Publicado: (2011)

Hemorrhage of MRI and Immunohistochemical Panels Distinguish Secretory Carcinoma From Acinic Cell Carcinoma
por: Kuwabara, Hiroko, et al.
Publicado: (2018)

Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma
por: Zizzi, Antonio, et al.
Publicado: (2013)

Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma
por: Ch’ng, Ewe Seng
Publicado: (2021)

CT and clinical features for distinguishing endophytic clear cell renal cell carcinoma from urothelial carcinoma
por: Chen, Xin, et al.
Publicado: (2022)

Extrapulmonary Small Cell Carcinoma of the Liver: Clinicopathological and Immunohistochemical Findings
por: Choi, Suk Jin, et al.
Publicado: (2007)

Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years
por: Weyerer, Veronika, et al.
Publicado: (2017)

Nuclear size measurement for distinguishing urothelial carcinomas from reactive urothelium on tissue sections
por: Poropatich, Kate, et al.
Publicado: (2016)

A case of pyelocalyceal diverticulum urothelial carcinoma that was difficult to distinguish from cystic renal cell carcinoma preoperatively
por: Matsuda, Iori, et al.
Publicado: (2021)

Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
por: Sung, Jong Jin, et al.
Publicado: (2016)

Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro
por: Wen, Jin, et al.
Publicado: (2015)

Collision metastasis of prostatic adenocarcinoma and urothelial carcinoma of the bladder
por: Sellman, David P., et al.
Publicado: (2018)

Metastatic Prostate Cancer to the Urethra Masquerading as Urothelial Carcinoma
por: Zardawi, Ibrahim, et al.
Publicado: (2016)

Immunohistochemical Investigation of HER/AKT/mTOR Pathway and Cellular Adhesion Molecules in Urothelial Carcinomas
por: Koletsas, Nikolaos, et al.
Publicado: (2017)

Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study
por: Florianova, Livia, et al.
Publicado: (2015)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile
por: Yamashita, Takashi, et al.
Publicado: (2023)

Brain and Skin Metastasis From Urothelial Carcinoma of the Bladder
por: Chung, Jae Hoon, et al.
Publicado: (2013)

Urothelial Carcinoma
por: Chow, Nan-Haw, et al.
Publicado: (2012)

New miRNA Profiles Accurately Distinguish Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas from the Normal Kidney
por: Zaravinos, Apostolos, et al.
Publicado: (2014)

Editorial Comment to A case of pyelocalyceal diverticulum urothelial carcinoma that was difficult to distinguish from cystic renal cell carcinoma preoperatively
por: Kitagawa, Yasuhide
Publicado: (2021)

Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma
por: Kim, Bohyun, et al.
Publicado: (2021)

The Immunohistochemical Expression of SOX-10 in Urothelial Carcinoma and the Non Neoplastic Urothelium; and a Correlation with the Tumor Features
por: Amer, Samar, et al.
Publicado: (2022)

Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma
por: Setyo, Laura C., et al.
Publicado: (2023)

Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer
por: Abbas, Mahmoud, et al.
Publicado: (2023)

Gemcitabine maintenance versus observation after first-line chemotherapy in patients with metastatic urothelial carcinoma: a retrospective study
por: Kim, Hyunho, et al.
Publicado: (2020)

Metastatic brain tumor from urothelial carcinoma of the prostatic urethra
por: Morita, Kohei, et al.
Publicado: (2016)

Primary urothelial carcinoma of the prostate: A rare case report
por: Zhou, Jun, et al.
Publicado: (2019)

Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
por: Abdallah, Rania Abdallah, et al.
Publicado: (2019)

Prognostic Impact of APOBEC3B Expression in Metastatic Urothelial Carcinoma and Its Association with Tumor-Infiltrating Cytotoxic T Cells
por: Kim, Hyunho, et al.
Publicado: (2021)

Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component
por: de Brot, Simone, et al.
Publicado: (2021)

Correction: New miRNA Profiles Accurately Distinguish Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas from the Normal Kidney
Publicado: (2014)

Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes
por: Ravanini, Juliana Naves, et al.
Publicado: (2021)

Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ
por: Yoo, Daeseon, et al.
Publicado: (2023)

Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs
por: Liu, Dongze, et al.
Publicado: (2022)

Metastatic urothelial carcinoma()()
por: Gómez-Moyano, Elisabeth, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t7a4dm1vos6kn8sdb72ucbb1m2